For ordering this report   For more information about this report  

 

2004, Comprehensive Study of Pharmaceutical Intermediate / Bulk Producers

 

Outline of the report

Point
This study provides basic information that will help pharmaceutical companies seeking external sources of pharmaceutical materials
You will have a clear understanding of the strengths of companies of interest by reviewing the Outline of each company, which is presented on the head
Descriptions of production technologies have been updated coping with technological progress

An overall revision was made to the three earlier editions of the same publication - Vol. 1 (2003), Vol. 2 (2002), and Vol. 5 (2002). Putting these three volumes together, two revised editions have been published; this is the first portion of the study.

The latest edition of this publication covers a broad scope of topics, including business results, types of products, chemical compounds / technology focus, production capabilities, quality control system, GMP, DMF, environmental protection measures, research and development, affiliations, sales trends, listing of product items that obtained government approval, etc. All of these factors reflect the growing outsourcing trend, complying with the recent trends that have been marked in the pharmaceutical industry in Japan - the April 2005 enforcement of the amended Pharmaceutical Affairs Law, and pharmaceutical business strategies that are now being developed on an international basis

Title of the report 2004, Comprehensive Study of Pharmaceutical Intermediate / Bulk Producers
Date of issue 24/09/04
Volume A4 / 600 pages
Price 95,000JPY
Preorder price 89,000JPY
Produced by Seed Planning, Inc.
Note This report is written in Japanese.
Customers who need an English version:Please contact us.
Category Pharmaceutical materials / vendors
Market Research Report Electronics/IT Medical/biotechnology Health/nursing care/wellness

SPI-information is a website for SP Information selling marketing research reports produced in Japan and worldwide.